The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Does depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials
Open accessAbstract
Background Comorbid major depression has been associated with worse survival in patients with cancer. However, we do not know if treating depression improves survival. In the SMaRT Oncology-2 (good prognosis cancers) and SMaRT Oncology-3 (lung cancer, a poor prognosis cancer) trials, we found that a depression treatment programme, Depression Care for People with Cancer (DCPC), was effective in reducing comorbid major depression. In this analysis, we aimed to identify whether DCPC also had an effect on survival.Methods The trials were conducted in three cancer centres and their associated clinics in Scotland, UK. In SMaRT Oncology-2, outpatients with good prognosis cancers and major depression were randomly assigned in a 1:1 ratio to DCPC or usual care, with stratification (by trial centre) and minimisation (by age, primary cancer, and sex) with allocation concealment. In SMaRT Oncology-3, outpatients with lung cancer and major depression were randomly assigned (1:1 ratio) to DCPC or usual care with stratification (by trial centre) and minimisation (by age, sex, and cancer type) with allocation concealment. For this analysis, we obtained long-term data on deaths (all causes) in the SMaRT Oncology-2 and 3 trial participants, censored at July 31, 2015, and analysed survival as a trial outcome. We estimated unadjusted hazard ratios (HRs) for each trial using Cox regression, and pooled the log HRs in a fixed-effects meta-analysis.Findings We recruited 642 participants; between May 12, 2008, and May 13, 2011, 500 participants were recruited to the SMaRT Oncology-2 trial and between Jan 5, 2009, and Sept 9, 2011, 142 participants were recruited to the SMaRT Oncology-3 trial. We followed up SMaRT Oncology-2 and SMaRT Oncology-3 participants for a median of 5 years and 1 year, respectively. 135 (27%) of 500 SMaRT Oncology-2 participants and 114 (80%) of 142 SMaRT Oncology-3 participants died within this period. We found no significant effect of DCPC on survival in the total follow-up period for either SMaRT Oncology 2 (HR 1·02, 95% CI 0·72-1·42, p=0·93) or SMaRT Oncology-3 (HR 0·82, 95% CI 0·56-1·18, p=0·28; pooled HR 0·92, 95% CI 0·72-1·18, p=0·51).Interpretation DCPC is highly effective in improving depression and quality of life in depressed patients with cancer, but there was no evidence for a significant effect on survival. Despite the absence of an effect on length of life, the management of depression remains important for its beneficial effect on quality of life.Funding NIHR CLAHRC Oxford, Cancer Research UK, and the Chief Scientist Office of the Scottish Government.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, profound loss of interest and reduced activity were associated with non-response to SSRI antidepressants, but good response to augmentation with aripiprazole. 538”
From Time for united action on depression: a Lancet–World Psychiatric Association Commission (2022) · cites this paper as [538]
In the citing paper
“A depression treatment program improved depression and quality of life in cancer patients, but did not prolong survival145.”
From Mechanisms and treatment of late-life depression (2019) · cites this paper as [145]
Citations
Cites
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000678 · Cited by 7,482
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885
EFFECT OF PSYCHOSOCIAL TREATMENT ON SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER
Spiegel, D., Kraemer, H., Bloom, J., & Gottheil, E. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91551-1 · Cited by 2,353
Depression and cancer mortality: a meta-analysis
Pinquart, M., & Duberstein, P. R. (2010) · Psychological Medicine · doi:10.1017/s0033291709992285 · Cited by 1,083
Fawzy, F. I. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820210015002 · Cited by 1,028
Depression as a predictor of disease progression and mortality in cancer patients: A Meta‐Analysis
Satin, J. R., Linden, W., & Phillips, M. J. (2009) · Cancer · doi:10.1002/cncr.24561 · Cited by 972
Walker, J., Hansen, C. H., Martin, P., Symeonides, S., Ramessur, R., Murray, G., & Sharpe, M. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70313-x · Cited by 435
Self-citationDepression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review
Park, M., Katon, W. J., & Wolf, F. M. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.01.006 · Cited by 355
Farrokhi, F., Abedi, N., Beyene, J., Kurdyak, P., & Jassal, S. V. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.08.024 · Cited by 336
Depression after Stroke and Risk of Mortality: A Systematic Review and Meta-Analysis
Bartoli, F., Lillia, N., Lax, A., Crocamo, C., Mantero, V., Carrà, G., Agostoni, E., & Clerici, M. (2013) · Stroke Research and Treatment · doi:10.1155/2013/862978 · Cited by 273
Cited by
Time for united action on depression: a Lancet–World Psychiatric Association Commission
Herrman, H., Patel, V., Kieling, C., Berk, M., Buchweitz, C., Cuijpers, P., Furukawa, T. A., Kessler, R. C., Kohrt, B. A., Maj, M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02141-3 · Cited by 1,104
Depression and anxiety in patients with cancer
Pitman, A., Suleman, S., Hyde, N., & Hodgkiss, A. (2018) · BMJ · doi:10.1136/bmj.k1415 · Cited by 871
Mechanisms and treatment of late-life depression
Alexopoulos, G. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0514-6 · Cited by 592
Risk of Suicide After Cancer Diagnosis in England
Henson, K. E., Brock, R., Charnock, J., Wickramasinghe, B., Will, O., & Pitman, A. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3181 · Cited by 247
“Models that integrate psychological support into cancer care, specifically collaborative screening and treatment, have shown benefits in terms of reduced depression, anxiety, and pain, even if they lack evidence for survival benefits.(31) Accesstothemeansofsuicidemayinfluencerisk,andrestrictingaccessisthesuicidepreven…”
BackgroundPrehabilitation in thoracic surgery
Sánchez-Lorente, D., Navarro‐Ripoll, R., Guzmán, R., Moisés, J., Gimeno, E., Boada, M., & Molins, L. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.08.18 · Cited by 148
Metadata
- Authors
- Mulick, A., Walker, J., Puntis, S., Burke, K., Symeonides, S., Gourley, C., Wanat, M., Frost, C., & Sharpe, M.
- Affiliations
- London School of Hygiene & Tropical Medicine (GB)
- Warneford Hospital (GB)
- Western General Hospital (GB)
- Corresponding author
- Sharpe, Michael
- ORCID
- Venue
- The Lancet Psychiatry
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 5
- Issue
- 4
- Pages
- 321-326
- ISSN
- 2215-0366 (ISSN-L)
- OpenAlex
- W2793857438
- Cited by
- 60
- References
- 25
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 5 · 2023: 4 · 2022: 7 · 2021: 7 · 2020: 9 · 2019: 6 · 2018: 9
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Cancer Research UK (grant no. C5547/A7375)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- depression, cancer, depression treatment, survival, lung cancer, comorbid depression, all-cause mortality, long-term follow-up, psychological intervention, prognostic factors for survival, randomized controlled trials, meta-analysis of trials, pooled hazard ratio, fixed-effects meta-analysis
- MeSH terms
- Aged, Depressive Disorder, Major, Major Depressive Disorder, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasms, Quality of Life, Scotland, Comorbidity, Survival Analysis, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Does depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials. https://app.cochat.ai/papers/10.1016/s2215-0366(18)30061-0
- The paper
- Mulick, A., Walker, J., Puntis, S., Burke, K., Symeonides, S., Gourley, C., Wanat, M., Frost, C., & Sharpe, M. (2018). Does depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials. The Lancet Psychiatry. https://doi.org/10.1016/s2215-0366(18)30061-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.